Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 6 Issue 12

A Case of Primitive Open Angle Glaucoma Conversion of an Isolated Ocular Hypertonia

Akono Zoua M1,2*, Mvilongo C1,2, Nomo Arlette1,3, Nanfack N Chantal1,3, Epée E1,2 and Omgbwa Eballe A1,4

1Faculty of Medicine and Biomedical Sciences, University of Yaounde I
1Yaoundé Central Hospital
1Yaounde Gyneco Pediatric Hospital
1Djoungolo District Hospital

*Corresponding Author: Akono Zoua M, Faculty of Medicine and Biomedical Sciences of University of Yaounde I.

Received: November 08, 2022; Published: November 24, 2022

Abstract

Introduction: Conversion of isolated ocular hypertonia to glaucoma is rare. We report one case, after 03 years of follow-up.

Observation: This is a 56-year-old female patient, with a history of high blood pressure, who came to consult for headaches evolving for 02 years. The initial ophthalmological examination showed corrected intraocular pressures of 27 mmHg and 30 mmHg respectively. Gonioscopy was normal in both eyes. At the fundus were vertical papillary excavations of 0.2 in both eyes. Initial automated visual field examination (Octopus) was normal, as was OCT of the optic nerve. Simple monitoring was advocated.

The persistence 6 months later of hypertonia at 31 mmHg on the right and 26 mmHg on the left, with visual fields and OCT of the normal optic nerves, motivated the prescription of Carteolol 2% eye drops.

The control carried out 3 years after the initial diagnosis, showed glaucomatous lesions to the visual and OCT fields of the optic nerve. The diagnosis of primary open-angle glaucoma was retained.

Bottom Line: Isolated ocular hypertonia can convert to chronic glaucoma despite hypotonic treatment.

Keywords: Isolated Ocular Hypertonia; Glaucoma; Conversion

References

  1. Jean-Paul Renard. “When and how to treat ocular hypertonia”. Les Cahiers d'Ophtalmologie 194 (2015): 28-32,40, 28-40.
  2. Sommer A., et al. “Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey”. Archives of Ophthalmology 109 (1991): 1090-1095.
  3. Leske MC., et al. “Risk factors for open-angle glaucoma: The Barbados eye Study”. Archives of Ophthalmology 113 (1995): 918-924.
  4. Gordon MO., et al. “The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma”. Archives of Ophthalmology 120 (2002): 714-720.
  5. Gordon MO and Kass MA. “What We Have Learned from the Ocular Hypertension Treatment Study”. American Journal of Ophthalmology 189 (2018): xxiv-xxvii.
  6. Fox JP and Nordmann JF. “Assessment of isolated intraocular hypertension”. In: Renard JP, Sellem E, eds. Primary open-angle glaucoma. SFO Report 2014. Elsevier Masson, (2014): 350-358.
  7. C Schweitzer. “Isolated ocular hypertonia: when to treat? When to do a simple follow-up?” Ophthalmological Realities 250 (2018): 54-55.
  8. Noche CD., et al. “Central corneal thickness in black Cameroonian ocular hypertensive and glaucomatous subjects”. Clinical Ophthalmology 4 (2010): 1371-1377.
  9. Tielsch JM., et al. “A population-based evaluation of glaucoma screening: the Baltimore Eye Survey”. American Journal of Epidemiology 134 (1991): 1102-1110.
  10. Kass MA., et al. “The Ocular Hypertension Study: randomized trial determines that topical ocular hypertensive medication delays or prevents the onset of primary open angle glaucoma”. Archives of Ophthalmology6 (2002): 701-713.
  11. JP Renard., et al. “Balance sheet in practice. Isolated ocular hypertonia”. Journal Français D'Ophtalmologie 28 (2005): Hors-série 2, 2S13-2S16. 13-16, Masson, Paris, 2005.
  12. Eballe AO., et al. “Central corneal thickness and intraocular pressure in the Cameroonian nonglaucomatous population”. Clinical Ophthalmology 4 (2010): 717-724.

Citation

Citation: Akono Zoua M., et al. “The Neonates' Body Length and Body Weight in Two Different Periods of Time”.Acta Scientific Medical Sciences 6.12 (2022): 103-108.

Copyright

Copyright: © 2022 Akono Zoua M., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US